Steroid mystery: study aims to personalize dosing for kids
NCT ID NCT02252237
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 146 children taking common steroids (prednisone, prednisolone, methylprednisolone, hydrocortisone) to understand why their bodies process these drugs so differently. By analyzing blood samples and genetic factors, researchers hope to find clues that could lead to safer, more effective dosing. The study is complete and focused on gathering knowledge, not testing a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Prednisone, prednisolone, methylprednisolone, hydrocortisone (corticosteroids)
- What this could lead to
- If successful, this could lead to more personalized steroid dosing for children, reducing side effects and improving treatment effectiveness.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly change clinical practice, and results may not apply to all children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN RECEIVING PREDNISONE OR PREDNISOLONE OR METHYLPREDNISOLONE OR HYDROCORTISONE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP Necker
Paris, 75015, France